Rosetta Genomics Ltd. Marketable Securities (Current)
Rosetta Genomics Ltd. had Marketable Securities (Current) of $0 as of 2011-12-31, per its 6-K filed 2012-12-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2012-12-07
- 2011-12-31: Marketable Securities, Current $0.00.
- 2010-12-31: Marketable Securities, Current $148.00K.
| Period end | Marketable Securities, Current |
|---|---|
| 2011-12-31 | $0.00 6-K · filed 2012-12-07 |
| 2010-12-31 | $148.00K 6-K · filed 2012-12-07 |